Biggest News Aggregation in the World
📰 Heca News

Page 9 - Heca News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Heca. Real-time updates on events, politics, business and more.

U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 mln

An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals /CRISPR Therapeutics and bluebird bio to as much as $2.05 mln, saying the new price can be cost effective to treat sickle cell disease.
United States Bhanvi Satija Vertex Pharmaceuticals Institute For Clinical Thomson Reuters Trust Principles Economic Review

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science